1. Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation

   • Nazrul Islam
   • Emma Cichero
   • Isuru Ranasinghe

   Leading Article Open access 18 October 2022 Pages: 1 - 7

   

2. Challenges and Possible Solutions to Direct-Acting Oral Anticoagulants (DOACs) Dosing in Patients with Extreme Bodyweight and Renal Impairment

   • Ezekwesiri Michael Nwanosike
   • Wendy Sunter
   • Syed Shahzad Hasan

   Current Opinion 14 December 2022 Pages: 9 - 17

   

3. Adherence and Discontinuation of Disease-Specific Therapies for Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis

   • Sami Qadus
   • Abdallah Y. Naser
   • Danny Liew

   Systematic Review 25 November 2022 Pages: 19 - 33

   

4. Very Short Versus Longer Dual Antiplatelet Treatment After Coronary Interventions: A Systematic Review and Meta-analysis

   • Grigorios Tsigkas
   • Anastasios Apostolos
   • Periklis Davlouros

   Systematic Review Open access 20 December 2022 Pages: 35 - 46

   

5. Cost-Effectiveness of Adding Empagliflozin to Standard Treatment for Heart Failure with Preserved Ejection Fraction Patients in China

   • Yake Lou
   • Tianyang Hu
   • Jing Huang

   Original Research Article 08 October 2022 Pages: 47 - 57

   

6. A Real-World Matched Cohort Study of the Effect of Concomitant Amiodarone or Diltiazem Administration on Apixaban Peak and Trough Concentrations

   • David A. Bookstaver
   • Michael Ainsworth
   • Erin Milner

   Original Research Article 31 October 2022 Pages: 59 - 66

   

7. Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins

   • R. Brett McQueen
   • Seth J. Baum
   • Kausik K. Ray

   Original Research Article Open access 31 October 2022 Pages: 67 - 76

   

8. Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry

   • Michele Millesimo
   • Edoardo Elia
   • Gaetano Maria De Ferrari

   Original Research Article 31 October 2022 Pages: 77 - 87

   

9. Statins Reduce Bleeding Risk in Patients Taking Oral Anticoagulants for Nonvalvular Atrial Fibrillation: A Retrospective Registry Study

   • Kazutaka Uchida
   • Shinichiro Ueda
   • Takeshi Morimoto

   Original Research Article 16 November 2022 Pages: 89 - 99

   

10. Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial

    • Qiang Zhou
    • Zhiqiang Wang
    • Wei Hu

    Original Research Article 09 January 2023 Pages: 101 - 112